While chronic bacterial infections and inflammation are associated with progressive lung disease in cystic fibrosis (CF) patients, much less is known regarding the contributions of respiratory viral infections to this process. Clinical studies suggest that antiviral host defenses may be compromised in individuals with CF, and CF airway epithelia exhibit impaired antiviral responses in vitro. Here, we used the CF pig model to test the hypothesis that the antiviral activity of respiratory secretions is reduced in CF. We developed an in vitro assay to measure the innate antiviral activity present in airway surface liquid (ASL) from CF and non-CF pigs. We found that tracheal and nasal ASL from newborn non-CF pigs exhibited dose-dependent inhibitory activity against several enveloped and encapsidated viruses including Sendai virus (SeV), respiratory syncytial virus (RSV), influenza A, and adenovirus. Importantly, we found that the anti-SeV activity of nasal ASL from newborn CF pigs was significantly diminished relative to non-CF littermate controls. This diminution of extracellular antiviral defenses appears to be driven, at least in part, by the differences in pH between CF and non-CF ASL. These data highlight the novel antiviral properties of native airway secretions, and suggest the possibility that defects in extracellular antiviral defenses contribute to CF pathogenesis.
|Journal||American Journal of Respiratory Cell and Molecular Biology|
|Early online date||26 Jun 2019|
|Publication status||Published - Jan 2020|